Literature DB >> 18160823

Stem cell differentiation: cardiac repair.

Michael Rubart1, Loren J Field.   

Abstract

Cellular transplantation has been employed for several years to deliver donor cardiomyocytes to normal and injured hearts. Recent reports of a variety of stem cells with apparent cardiomyogenic potential have raised the possibility of cell transplantation-based therapeutic interventions for heart disease. Here we review the preclinical studies demonstrating that intracardiac transplantation of skeletal myoblasts, cardiomyocytes and cardiomyogenic stem cells is feasible. In addition, recent clinical studies of skeletal myoblast and adult stem cell transplantation for heart disease are discussed. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 18160823      PMCID: PMC2605419          DOI: 10.1159/000112846

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.481


  73 in total

1.  Differentiation and lineage selection of mouse embryonic stem cells in a stirred bench scale bioreactor with automated process control.

Authors:  Magnus Schroeder; Sylvia Niebruegge; Andreas Werner; Elmar Willbold; Monika Burg; Manfred Ruediger; Loren J Field; Juergen Lehmann; Robert Zweigerdt
Journal:  Biotechnol Bioeng       Date:  2005-12-30       Impact factor: 4.530

Review 2.  Cardiac repair by embryonic stem-derived cells.

Authors:  M Rubart; L J Field
Journal:  Handb Exp Pharmacol       Date:  2006

3.  Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.

Authors:  Gerd P Meyer; Kai C Wollert; Joachim Lotz; Jan Steffens; Peter Lippolt; Stephanie Fichtner; Hartmut Hecker; Arnd Schaefer; Lubomir Arseniev; Bernd Hertenstein; Arnold Ganser; Helmut Drexler
Journal:  Circulation       Date:  2006-03-06       Impact factor: 29.690

4.  Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.

Authors:  Stefan Janssens; Christophe Dubois; Jan Bogaert; Koen Theunissen; Christophe Deroose; Walter Desmet; Maria Kalantzi; Lieven Herbots; Peter Sinnaeve; Joseph Dens; Johan Maertens; Frank Rademakers; Steven Dymarkowski; Olivier Gheysens; Johan Van Cleemput; Guy Bormans; Johan Nuyts; Ann Belmans; Luc Mortelmans; Marc Boogaerts; Frans Van de Werf
Journal:  Lancet       Date:  2006-01-14       Impact factor: 79.321

5.  Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients.

Authors:  Albert A Hagège; Jean-Pierre Marolleau; Jean-Thomas Vilquin; Armelle Alhéritière; Séverine Peyrard; Denis Duboc; Eric Abergel; Emmanuel Messas; Elie Mousseaux; Ketty Schwartz; Michel Desnos; Philippe Menasché
Journal:  Circulation       Date:  2006-07-04       Impact factor: 29.690

6.  Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial.

Authors:  Dietlind Zohlnhöfer; Ilka Ott; Julinda Mehilli; Kathrin Schömig; Fabian Michalk; Tareq Ibrahim; Günther Meisetschläger; Jasper von Wedel; Hildegard Bollwein; Melchior Seyfarth; Josef Dirschinger; Claus Schmitt; Markus Schwaiger; Adnan Kastrati; Albert Schömig
Journal:  JAMA       Date:  2006-03-01       Impact factor: 56.272

7.  Pluripotency of spermatogonial stem cells from adult mouse testis.

Authors:  Kaomei Guan; Karim Nayernia; Lars S Maier; Stefan Wagner; Ralf Dressel; Jae Ho Lee; Jessica Nolte; Frieder Wolf; Manyu Li; Wolfgang Engel; Gerd Hasenfuss
Journal:  Nature       Date:  2006-03-24       Impact factor: 49.962

8.  G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis.

Authors:  Elisabeth Deindl; Marc-Michael Zaruba; Stefan Brunner; Bruno Huber; Ursula Mehl; Gerald Assmann; Imo E Hoefer; Josef Mueller-Hoecker; Wolfgang-Michael Franz
Journal:  FASEB J       Date:  2006-03-29       Impact factor: 5.191

9.  Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement.

Authors:  Massimiliano Gnecchi; Huamei He; Nicolas Noiseux; Olin D Liang; Lunan Zhang; Fulvio Morello; Hui Mu; Luis G Melo; Richard E Pratt; Joanne S Ingwall; Victor J Dzau
Journal:  FASEB J       Date:  2006-04       Impact factor: 5.191

10.  Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial.

Authors:  Rasmus Sejersten Ripa; Erik Jørgensen; Yongzhong Wang; Jens Jakob Thune; Jens Christian Nilsson; Lars Søndergaard; Hans Erik Johnsen; Lars Køber; Peer Grande; Jens Kastrup
Journal:  Circulation       Date:  2006-03-12       Impact factor: 29.690

View more
  10 in total

1.  Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition.

Authors:  Yerem Yeghiazarians; Meenakshi Gaur; Yan Zhang; Richard E Sievers; Carissa Ritner; Megha Prasad; Andrew Boyle; Harold S Bernstein
Journal:  Cytotherapy       Date:  2011-10-31       Impact factor: 5.414

Review 2.  Translational lessons from scarless healing of cutaneous wounds and regenerative repair of the myocardium.

Authors:  Joseph A Palatinus; J Matthew Rhett; Robert G Gourdie
Journal:  J Mol Cell Cardiol       Date:  2009-06-25       Impact factor: 5.000

3.  Enhanced mobilization of CD34(+) progenitor cells expressing cell adhesion molecules in patients with STEMI.

Authors:  Michael Brehm; Petra Ebner; Frauke Picard; Ryan Urbien; Gökmen Turan; Bodo-Eckehard Strauer
Journal:  Clin Res Cardiol       Date:  2009-05-29       Impact factor: 5.460

4.  Special issue on recent progress with hPSC-derived cardiovascular cells for organoids, engineered myocardium, drug discovery, disease models, and therapy.

Authors:  Kenneth R Boheler; Albano C Meli; Huang-Tian Yang
Journal:  Pflugers Arch       Date:  2021-06-16       Impact factor: 3.657

5.  Embryonic stem cell-derived cardiomyocyte heterogeneity and the isolation of immature and committed cells for cardiac remodeling and regeneration.

Authors:  Kenneth R Boheler; Robert N Joodi; Hui Qiao; Ondrej Juhasz; Amanda L Urick; Sandra L Chuppa; Rebekah L Gundry; Robert P Wersto; Rong Zhou
Journal:  Stem Cells Int       Date:  2011-09-06       Impact factor: 5.443

6.  Functional and histopathological improvement of the post-infarcted rat heart upon myoblast cell grafting and relaxin therapy.

Authors:  Massimo Bonacchi; Silvia Nistri; Cristina Nanni; Sandro Gelsomino; Alessandro Pini; Lorenzo Cinci; Massimo Maiani; Sandra Zecchi-Orlandini; Roberto Lorusso; Stefano Fanti; Josh Silvertown; Daniele Bani
Journal:  J Cell Mol Med       Date:  2008-09-15       Impact factor: 5.310

Review 7.  Cell shape and cardiosphere differentiation: a revelation by proteomic profiling.

Authors:  Nanako Kawaguchi; Mitsuyo Machida; Kota Hatta; Toshio Nakanishi; Yohtaroh Takagaki
Journal:  Biochem Res Int       Date:  2013-09-01

8.  Over expression of Plk1 does not induce cell division in rat cardiac myocytes in vitro.

Authors:  Carmen H Coxon; Katrina A Bicknell; Fleur L Moseley; Gavin Brooks
Journal:  PLoS One       Date:  2009-08-25       Impact factor: 3.240

9.  Personalized cardiac regeneration by stem cells-Hype or hope?

Authors:  Ulrich Marc Becher; Vedat Tiyerili; Dirk Skowasch; Georg Nickenig; Nikos Werner
Journal:  EPMA J       Date:  2011-03-05       Impact factor: 6.543

Review 10.  Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction.

Authors:  Anne-Laure Leblond; John O'Sullivan; Noel Caplice
Journal:  Stem Cells Cloning       Date:  2009-12-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.